Why the study?
Pulmonary vein isolation has limited efficacy in persistent atrial fibrillation, while strategies combining PVI, vein of Marshall ethanol infusion, and anatomical isthmus ablation have shown promising short-term outcomes.
Comparison
VOM-EI + AS vs PVI-only
Design
Retrospective multicenter observational cohort study
Follow-up
Median 22-month
Key result
A first ablation strategy incorporating vein of Marshall ethanol infusion and anatomical linear lesions resulted in 81% freedom from atrial arrhythmias compared to 47% with PVI alone (p<0.001).
Authors
Loading...
Multicenter cohort study demonstrates superior arrhythmia-free survival with vein of Marshall ethanol infusion in persistent atrial fibrillation, indicating clear benefits over isolation alone.
Cohort (n=226)
Yes
Absolute Event Rate: 81% vs 47%
p-value: p=<0.001
Iavarone et al. (2026) conducted a cohort in Persistent atrial fibrillation (n=226). Vein of Marshall ethanol infusion (VOM-EI) + anatomical ablation strategy (AS) vs. Pulmonary vein isolation (PVI) only was evaluated on Freedom from atrial arrhythmias lasting > 30 s off antiarrhythmic drugs (p=<0.001). A first ablation strategy incorporating vein of Marshall ethanol infusion and anatomical linear lesions resulted in 81% freedom from atrial arrhythmias compared to 47% with PVI alone (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: